<DOC>
	<DOCNO>NCT00041925</DOCNO>
	<brief_summary>The purpose study determine efficacy graft pretreatment E2F decoy , CGT003 , compare placebo , occurrence graft failure among patient receive autogenous vein graft treat chronic critical limb ischemia ; occurrence clinically significant graft stenosis ( equal 70 % ) ; incidence critical limb ischemia ( e.g. , gangrene , non-healing ischemic ulcer ischemic rest pain ) .</brief_summary>
	<brief_title>Prevention Autogenous Vein Graft Failure Peripheral Artery Bypass Procedures</brief_title>
	<detailed_description>Peripheral vascular disease manifest narrowing peripheral artery one common manifestation atherosclerotic vascular disease . Complications claudication , rest pain , impair wound heal frequent may result gangrene amputation . Restoration circulation low extremity may undertake use variety technique include angioplasty , stenting , bypass grafting . Approximately 99,000 infra-inguinal bypass procedure perform U.S. 1998 . It estimate approximately 22 % infra-inguinal bypass graft fail 12 month . Graft failure rate estimate increase 40 % 12 month patient receive composite , cephalic lesser saphenous ( high-risk ) vein graft ( Vascular Surgery Registry , Brigham Women â€™ Hospital ) . These primary graft failure typically due stenosis result neointimal hyperplasia , pathological adaptation process occur vein expose arterial circulation . The consequence graft failure significant primary atherosclerotic disease include ischemia poor wound heal may result amputation . Since long-term patency venous graft improve treatment prior frank occlusion , considerable effort focus method detection graft high-risk failure . Duplex ultrasonography determine sensitive screen test early detection fail graft . Peak systolic velocity ( PSV ) , measure duplex ultrasound , show sensitive marker low flow , wave form analysis permit identification area stenosis vein study . Management patient undergone infra-inguinal bypass therefore include routine surveillance duplex ultrasound immediate correction significant ( equal 70 % ) graft stenosis .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Graft Occlusion , Vascular</mesh_term>
	<criteria>PATIENTS MUST : Be schedule undergo infrainguinal bypass graft surgery use excise autogenous vein Chronic Critical Limb Ischemia ( i.e. , rest pain , nonhealing ulceration gangrene ) . For patient present rest pain manifestation CCLI , must diagnosis confirm least one follow , : . ) ankle pressure &lt; 50 mmHg ( ABI &lt; 0.4 ) , ii . ) toe pressure &lt; 30 mmHg , iii . ) reduce TCPO2 &lt; 30 mmHg , iv . ) severely ischemic flat line transtarsal pulse volume record ( i.e. , Category V ) . Be male female least 18 year old . Have agree participate voluntarily sign date IRBapproved , Patient Informed Consent form . Have document negative serum pregnancy test woman childbearing potential . Be use acceptable method birth control reproductive potential . Note : Patients undergo operation replace previously occlude graft involve placement entirely new bypass graft ARE eligible study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>atherosclerotic vascular disease</keyword>
	<keyword>chronic critical limb ischemia</keyword>
	<keyword>neointimal hyperplasia</keyword>
	<keyword>peripheral vein bypass</keyword>
	<keyword>infra-inguinal bypass grafting surgery</keyword>
	<keyword>graft stenosis</keyword>
	<keyword>occlude graft</keyword>
</DOC>